Romofab Holding ApS: Financial statements 2020
CVR: 38556797
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Romofab Holding ApS (CVR 38556797) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -15,000 and a net result of DKK -17,996 compared with DKK -18,209 the year before. Equity in the 2020 report amounted to DKK 435,670. The solvency ratio was 87.1%.
- Gross Profit
- DKK -15,000
- Profit/Loss
- DKK -17,996
- Equity
- DKK 435,670
- Total Assets
- DKK 500,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -15 t. | -18 t. | 436 t. | 0 |
| 2019 | - | -15 t. | -18 t. | 454 t. | - |
| 2018 | - | -12 t. | -12 t. | 472 t. | - |
Official annual report
How creditworthy is Romofab Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Romofab Holding ApS has published its annual report for 2019. Gross profit came to DKK -15,000, and the net result was DKK -18,209.
About Romofab Holding ApS
Romofab Holding ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Molly Bilde Fabrin and Robert Fabrin. The company is owned by Robert Fabrin and Molly Bilde Fabrin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -13,750 and a net result of DKK 284,766 compared with DKK -2,029,900 the year before. Equity in the 2025 report amounted to DKK -1,399,345.